With an in-line performance expected in Q3, ABT stock may trade sideways next week. However, we would watch out for its ...

Abbott (NYSE: ABT) recently reported its Q3 results, with revenues and earnings slightly above our expectations.

Abbott and Reckitt's Mead Johnson will not be allowed to show jurors a statement by U.S. government agencies and a government ...

Abbott Laboratories narrowed its full-year profit outlook, raising the midpoint slightly, as strong demand for its diabetes ...

The CEO at the Illinois-based company with operations in Minnesota expects earning to return to a pre-pandemic profit model ...

Abbott Laboratories, a healthcare giant with diverse divisions, is normalizing post-pandemic as its medical devices drive ...

A new device from Abbott Laboratories, called Lingo, is geared toward people who don’t have diabetes but want to see how food ...

If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing ...

To help affected families and communities, Abbott and Abbott Fund are working with our longstanding disaster relief partner ...

Key Takeaways Abbott Laboratories beat third-quarter profit and sales estimates on strong demand for its medical ...

Pharma companies also are known for paying dividends, offering you a guaranteed stream of annual revenue. Below are three ...

Abbott Laboratories is a diversified healthcare company with strong segments, particularly Medical Devices. Read why I assign ...